Summary:
A multicentre randomized, double-blind, placebocontrolled, dose-finding, Phase 2 study (MARS-17) of GSK3858279 in adult participants with moderate to severe pain due to knee osteoarthritis
Qualified Participants Must:
• Male or female aged 40 to 80 years of age
•
Have active knee pain